Randomized controlled trials for alcohol use disorder during the COVID-19 pandemic
- PMID: 33434615
- PMCID: PMC7832637
- DOI: 10.1016/j.alcohol.2021.01.001
Randomized controlled trials for alcohol use disorder during the COVID-19 pandemic
Abstract
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) altered the logistics of ongoing randomized controlled trials (RCTs). The need to reduce in-person research and clinical activities, however, presented an additional level of complexity in order to continue conducting RCTs that focused on the development of medications for Alcohol Use Disorder (AUD). The visits required a systematic objective evaluation from the physician and mental health professional and clinical staff, as many of the safety and efficacy assessments are self-reported. The following commentary addresses the successes and limitations our RCTs encountered during the coronavirus (COVID-19) pandemic.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have declared that no conflict of interest exists. There are no relationships between financial supporters or other organizations and these authors that could have influenced the study and results.
References
-
- Czeisler M.É., Lane R.I., Petrosky E., Wiley J.F., Christensen A., Njai R., et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic – United States, June 24–30, 2020. Morbidity and Mortality Weekly Report. 2020;69(32):1049–1057. doi: 10.15585/mmwr.mm6932a1. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
